Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Efficacy and Safety of TELMINUVO to Stage 2 Hypertension [Phase 3]
This Phase 3 clinical trial update reports on the efficacy and safety of TELMINUVO for stage 2 hypertension.
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: 1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy [Phase 4]
A completed Phase 4 trial compared telmisartan 80 mg to valsartan 160 mg over one year in hypertensive patients with type 2 diabetes and ove…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Practice-based Trial of Blood Pressure Control in African Americans [Phase 3]
A Phase 3 clinical trial evaluating blood pressure control in African American patients has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients [Phase 3]
An open-label Phase 3 follow-up study evaluating the fixed-dose combination of telmisartan and hydrochlorothiazide in patients with hyperten…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Behavioral Study to Control Blood Pressure [Phase 2, Phase 3]
This trial update reports completion of Phase 2 and Phase 3 of a behavioral study aimed at controlling blood pressure in hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-11-08FDA Approved: CLEVIPREX — Supplemental Application (Fresenius Kabi Austria GmbH)
The FDA approved a supplemental application for CLEVIPREX (clevidipine), submitted by Fresenius Kabi Austria GmbH. The action is categorized…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension [Phase 2]
This update notes the completion of a Phase 2 3x3 factorial trial evaluating telmisartan with hydrochlorothiazide in patients with essential…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients [Phase 3]
Phase 3 trial results were posted evaluating the vascular effects of carvedilol controlled-release in abdominally obese hypertensive patient…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes [Phase 4]
A completed Phase 4 trial comparing telmisartan and ramipril for effects on renal endothelial dysfunction in patients with type 2 diabetes a…
-
FDA approval · 2013-11-08FDA Approved: FELODIPINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic felodipine under an Abbreviated New Drug Application by Heritage Pharmaceuticals (Avet) to treat hypertension and ang…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives
An observational, non-interventional study evaluating telmisartan in high-risk hypertension patients has been completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: SMOOTH - Blood Pressure Control in Diabetic/Obese Patients [Phase 4]
Phase 4 clinical trial SMOOTH evaluated blood pressure control in adults with hypertension and type 2 diabetes, including obese participants…
-
FDA approval · 2013-11-07FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for amlodipine and atorvastatin (amlodipine besylate and atorvastatin calci…
-
FDA approval · 2013-11-06FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for doxazosin by Mylan Pharmaceuticals Inc., indicating approval of the supplemental request.
-
FDA approval · 2013-11-06FDA Approved: METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved a generic combination product of metoprolol tartrate and hydrochlorothiazide for the treatment of hypertension.
-
FDA label_change · 2013-11-05FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) by Almatica Pharma Inc., resulting in changes to…
-
FDA label_change · 2013-11-05FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for ZESTRIL (lisinopril) submitted by Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin [Phase 1]
A Phase 1 pharmacokinetic study comparing a fixed-dose combination of telmisartan and rosuvastatin to taking the two drugs separately in ind…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients [Phase 4]
A Phase 4 randomized, double-blind trial comparing telmisartan/hydrochlorothiazide against valsartan/hydrochlorothiazide in patients with st…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients [NA]
This completed clinical trial from Wayne State University studied pre-clinical cardiac dysfunction in asymptomatic hypertensive patients. Re…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Renal Denervation in Patients With Refractory Hypertension [Phase 1]
Phase 1 clinical trial examining renal denervation for refractory hypertension has completed enrollment and results. The study is sponsored …
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Renal Denervation in Patients With Refractory Hypertension [NA]
A clinical trial evaluating renal denervation for refractory hypertension has completed, with the status listed as COMPLETED.
-
FDA approval · 2013-11-04FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Aliskiren hemifumarate submitted by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Fat Gain and Cardiovascular Disease Mechanisms [Phase 3]
Phase 3 clinical trial update on fat gain and cardiovascular disease mechanisms has completed, examining links between obesity, hypertension…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia [Phase 3]
Phase 3 trial evaluating the combination of telmisartan and simvastatin for hypertension and hyperlipidemia has completed.